Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements), 2015 and in furtherance to letter dated 30.03.2021, Vivimed Labs has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, 28th Day of June, 2021 at Hyderabad to consider and approve audited Financial Results (Standalone & Consolidated) of the company for the quarter and year ended 31st March, 2021. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has intimated its ‘Designated Persons including Directors’ regarding the closure of trading window from 01.04.2021 to till 48 hours after the declaration of audited Financial Results (Standalone & Consolidated) of the company for the quarter and year ended 31st March, 2021.
The above information is a part of company’s filings submitted to BSE.
